Your browser doesn't support javascript.
loading
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma.
Awwad, Mohamed H S; Kriegsmann, Katharina; Plaumann, Julian; Benn, Michael; Hillengass, Jens; Raab, Marc S; Bertsch, Uta; Munder, Markus; Weisel, Katja; Salwender, Hans Jürgen; Hänel, Mathias; Fenk, Roland; Dürig, Jan; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael.
Afiliação
  • Awwad MHS; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Kriegsmann K; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Plaumann J; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Benn M; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Hillengass J; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Raab MS; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Bertsch U; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Munder M; National Center for Tumour Diseases, University of Heidelberg, Heidelberg, Germany.
  • Weisel K; Department of Hematology, Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Salwender HJ; Department of Hematology, Oncology, Immunology and Rheumatology, University of Tübingen, Tübingen, Germany.
  • Hänel M; Asklepios Klinik Hamburg Altona, Germany.
  • Fenk R; Klinikum Chemnitz, Germany.
  • Dürig J; Department of Hematology, Oncology and Clinical Immunology, University Düsseldorf, Düsseldorf, Germany.
  • Müller-Tidow C; Department of Hematology, University of Essen, Essen, Germany.
  • Goldschmidt H; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Hundemer M; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
Oncoimmunology ; 7(10): e1486356, 2018.
Article em En | MEDLINE | ID: mdl-30288348
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article